Profil
Géraldine Honnet is currently the Chief Medical Officer at Sensorion SA since 2020.
Prior to this, she worked as the Director-Development at Genethon from 2017 to 2020, as a Senior Clinical Manager at Transgene SA from 2007 to 2011, and as a Medical Director at PAREXEL International Corp.
from 2001 to 2005.
Aktive Positionen von Géraldine Honnet
| Unternehmen | Position | Beginn |
|---|---|---|
| SENSORION | Technik-/Wissenschafts-/F&E-Leiter | 18.02.2020 |
Ehemalige bekannte Positionen von Géraldine Honnet
| Unternehmen | Position | Ende |
|---|---|---|
Genethon
Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Corporate Officer/Principal | 01.01.2020 |
| TRANSGENE | Corporate Officer/Principal | 01.04.2011 |
| PAREXEL INTERNATIONAL CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2005 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
PAREXEL International Corp.
PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Sensorion SA
Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Genethon
Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Health Technology |
















